Article Details

Neuren Pharmaceuticals (ASX:NEU) receives US patent for NNZ-2591 - The Market Herald

Retrieved on: 2021-10-11 03:00:00

Tags for this article:

Click the tags to see associated articles and topics

Neuren Pharmaceuticals (ASX:NEU) receives US patent for NNZ-2591 - The Market Herald. View article details on hiswai:

Excerpt

Neuren Pharmaceuticals (NEU) receives a Notice of Allowance from the US Patent and Trademark Office for NNZ-2591 to treat autism; The patent is titled ...

Article found on: themarketherald.com.au

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up